Cognito Therapeutics

Cognito Therapeutics is a clinical-stage biotechnology company developing disease‑modifying treatments to revive the health and well‑being of people living with Alzheimer’s disease. The company focuses on therapies designed to restore neuronal function and slow or reverse disease progression rather than only treating symptoms. Cognito advances candidates through translational neuroscience and clinical development with the goal of delivering transformative medicines to patients and families affected by Alzheimer’s.